The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124554253 12455425 3 F 201506 20160627 20160610 20160708 EXP GB-AMGEN-GBRSP2015121955 AMGEN 70.00 YR E F Y 0.00000 20160708 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124554253 12455425 1 PS ENBREL ETANERCEPT 1 Subcutaneous 50 MG, WEEKLY Y 103795 50 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE /wk
124554253 12455425 2 SS LEFLUNOMIDE. LEFLUNOMIDE 1 Oral 10 MG (ON MONDAYS, WEDNESDAYS AND FRIDAYS) 0 10 MG
124554253 12455425 3 SS LEFLUNOMIDE. LEFLUNOMIDE 1 Unknown UNK(FOUR TIMES A WEEK) 0
124554253 12455425 4 SS LEFLUNOMIDE. LEFLUNOMIDE 1 Oral FOUR TIMES A WEEK 0
124554253 12455425 5 C PREDNISOLONE. PREDNISOLONE 1 4 MG, DAILY 0 4 MG
124554253 12455425 6 C CELEBREX CELECOXIB 1 100 MG, TWICE DAILY 0 100 MG BID
124554253 12455425 7 C ADCAL /00056901/ CARBAZOCHROME 1 UNK 0
124554253 12455425 8 C CANDESARTAN CANDESARTAN 1 UNK 0
124554253 12455425 9 C DOXAZOSIN DOXAZOSINDOXAZOSIN MESYLATE 1 UNK 0
124554253 12455425 10 C LANSOPRAZOLE. LANSOPRAZOLE 1 UNK 0
124554253 12455425 11 C TOLTERODINE TOLTERODINE 1 4 MG, DAILY 0 4 MG
124554253 12455425 12 C TOLTERODINE TOLTERODINE 1 4 MG, DAILY 0 4 MG
124554253 12455425 13 C TOLTERODINE TOLTERODINE 1 4 MG, DAILY 0 4 MG
124554253 12455425 14 C TOLTERODINE TOLTERODINE 1 4 MG, DAILY 0 4 MG
124554253 12455425 15 C TOLTERODINE TOLTERODINE 1 4 MG, DAILY 0 4 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124554253 12455425 1 Rheumatoid arthritis
124554253 12455425 2 Rheumatoid arthritis
124554253 12455425 5 Rheumatoid arthritis
124554253 12455425 6 Rheumatoid arthritis
124554253 12455425 7 Osteopenia
124554253 12455425 8 Hypertension
124554253 12455425 9 Hypertension
124554253 12455425 10 Prophylaxis against gastrointestinal ulcer

Outcome of event

Event ID CASEID OUTC COD
124554253 12455425 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124554253 12455425 Anxiety
124554253 12455425 Atrial fibrillation
124554253 12455425 Blood pressure increased
124554253 12455425 Cardiac failure
124554253 12455425 Condition aggravated
124554253 12455425 Diarrhoea
124554253 12455425 Heart rate irregular
124554253 12455425 Injection site rash
124554253 12455425 Joint dislocation
124554253 12455425 Osteoarthritis
124554253 12455425 Pain
124554253 12455425 Palpitations
124554253 12455425 Rash
124554253 12455425 Rheumatoid arthritis
124554253 12455425 Sluggishness

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124554253 12455425 1 20150602 20160204 0
124554253 12455425 2 20141210 0
124554253 12455425 5 199609 0
124554253 12455425 6 1996 0
124554253 12455425 7 2010 0
124554253 12455425 8 2010 0
124554253 12455425 9 2011 0
124554253 12455425 10 2000 0